407 related articles for article (PubMed ID: 33777186)
1. Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice.
Kang K; Sun Y; Pan D; Sang LX; Sun MJ; Li YL; Chang B
Exp Ther Med; 2021 May; 21(5):418. PubMed ID: 33777186
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of flavonoids extract of Hippophae rhamnoides L. on alcoholic fatty liver disease through regulating intestinal flora and inhibiting TAK1/p38MAPK/p65NF-κB pathway.
Zhao H; Kong L; Shao M; Liu J; Sun C; Li C; Wang Y; Chai X; Wang Y; Zhang Y; Li X
J Ethnopharmacol; 2022 Jun; 292():115225. PubMed ID: 35341932
[TBL] [Abstract][Full Text] [Related]
3. Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis.
Zhang T; Li J; Liu CP; Guo M; Gao CL; Zhou LP; Long Y; Xu Y
Ann Transl Med; 2021 May; 9(10):873. PubMed ID: 34164507
[TBL] [Abstract][Full Text] [Related]
4. Oroxin B improves metabolic-associated fatty liver disease by alleviating gut microbiota dysbiosis in a high-fat diet-induced rat model.
Huang Y; Wang C; Wang M; Xiong T; Song X; Sun W; Li J
Eur J Pharmacol; 2023 Jul; 951():175788. PubMed ID: 37179040
[TBL] [Abstract][Full Text] [Related]
5. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
6. Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children.
Ji J; Sun J; Li J; Xie J; Xi B; Zhao M
Clin Nutr; 2024 Jan; 43(1):187-196. PubMed ID: 38070210
[TBL] [Abstract][Full Text] [Related]
7. [Effects of different swimming exercises on alcoholic fatty liver formation in mice].
Chen R; Chen W; Chen YL; Chen JQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jul; 38(4):341-347. PubMed ID: 36414559
[No Abstract] [Full Text] [Related]
8. Protection against Metabolic Associated Fatty Liver Disease by Protocatechuic Acid.
Tan J; Hu R; Gong J; Fang C; Li Y; Liu M; He Z; Hou DX; Zhang H; He J; Wu S
Gut Microbes; 2023; 15(1):2238959. PubMed ID: 37505920
[TBL] [Abstract][Full Text] [Related]
9. Phosphoesterase complex modulates microflora and chronic inflammation in rats with alcoholic fatty liver disease.
Ma D; Hu J; Xu W; Wang Y; Wang J; Li L; Wang S; Zhou H; Li Y; Liu L
Life Sci; 2020 Dec; 262():118509. PubMed ID: 33010280
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease.
Oh JH; Lee JH; Cho MS; Kim H; Chun J; Lee JH; Yoon Y; Kang W
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801023
[TBL] [Abstract][Full Text] [Related]
11. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance.
Kong L; Chen J; Ji X; Qin Q; Yang H; Liu D; Li D; Sun M
J Exp Clin Cancer Res; 2021 Jan; 40(1):18. PubMed ID: 33413501
[TBL] [Abstract][Full Text] [Related]
12. Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in Mice.
Bao T; He F; Zhang X; Zhu L; Wang Z; Lu H; Wang T; Li Y; Yang S; Wang H
Front Pharmacol; 2020; 11():558525. PubMed ID: 33390939
[No Abstract] [Full Text] [Related]
13. Effects of Tea against Alcoholic Fatty Liver Disease by Modulating Gut Microbiota in Chronic Alcohol-Exposed Mice.
Li B; Mao Q; Zhou D; Luo M; Gan R; Li H; Huang S; Saimaiti A; Shang A; Li H
Foods; 2021 May; 10(6):. PubMed ID: 34071491
[TBL] [Abstract][Full Text] [Related]
14. Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians:
Yuan H; Wu X; Wang X; Zhou JY; Park S
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396863
[TBL] [Abstract][Full Text] [Related]
15. Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.
Dong Y; Wu Z; Gai Z; Han M
J Appl Microbiol; 2023 Nov; 134(11):. PubMed ID: 37930723
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.
Xue M; Liu Y; Lyu R; Ge N; Liu M; Ma Y; Liang H
PLoS One; 2017; 12(6):e0178684. PubMed ID: 28622357
[TBL] [Abstract][Full Text] [Related]
17. Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.
Niu C; Tu Y; Jin Q; Chen Z; Yuan K; Wang M; Zhang P; Luo J; Li H; Yang Y; Liu X; Mao M; Dong T; Tan W; Hu X; Pan Y; Hou L; Ma R; Huang Z
Front Cell Infect Microbiol; 2023; 13():1157368. PubMed ID: 37180439
[TBL] [Abstract][Full Text] [Related]
18. [Berberine alleviates programmed necrosis of metabolic-associated fatty liver disease via activating Nrf2 pathway in mice].
Hao MY; Sun LL; Sheng MW; Lyu YS; Lin YB; Yang YH; Zhi JH; Yu WL; Du HY
Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):224-229. PubMed ID: 35359076
[No Abstract] [Full Text] [Related]
19. Assessing the
Wang Y; Wang Z; Wan Y; Jin F; Shi X; Xing Z; Tian B; Li B
Front Nutr; 2023; 10():1147423. PubMed ID: 37020807
[TBL] [Abstract][Full Text] [Related]
20. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
